Unknown NA INTERVENTIONAL 2-arm NCT04361357

The Effects of Enteral Whey Protein Supplement on Serum Albumin Level in Acute Critically Ill Neurological Patients

Sponsor: Xuanwu Hospital, Beijing

Conditions Neurologic Disorder Nutrition Disorders

Updated 6 times since 2020 Last updated: Feb 9, 2021 Started: Jan 5, 2020 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04361357, this NA trial focuses on Neurologic Disorder and Nutrition Disorders and remains ongoing. Sponsored by Xuanwu Hospital, Beijing, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Mar 2021 — Feb 2023 [monthly]

Recruiting NA
Jan 2021 — Mar 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

May 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xuanwu Hospital, Beijing

Data source: Xuanwu Hospital, Beijing

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China